(Q43955538)

28 November 2017

title

Prevalence of latent autoimmune diabetes of adults (LADA) in Southern Spain (English)

1 reference

28 November 2017

3

1 reference

28 November 2017

author name string

Federico Soriguer-Escofet

1

1 reference

28 November 2017

Isabel Esteva

2

1 reference

28 November 2017

Soledad Ruiz de Adana

4

1 reference

28 November 2017

Marieta Catalá

5

1 reference

28 November 2017

M José Merelo

6

1 reference

28 November 2017

Manuel Aguilar

7

1 reference

28 November 2017

Francisco Tinahones

8

1 reference

28 November 2017

José M García-Almeida

9

1 reference

28 November 2017

Juan M Gómez-Zumaquero

10

1 reference

28 November 2017

Antonio L Cuesta-Muñoz

11

1 reference

28 November 2017

José Ortego

12

1 reference

28 November 2017

José M Freire

13

1 reference

28 November 2017

Diabets Group of the Andalusian Society of Endocrinology and Nutrtion

14

1 reference

28 November 2017

publication date

1 June 2002

1 reference

Diabetes Research and Clinical Practice

28 November 2017

published in

1 reference

28 November 2017

volume

56

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

213-220

1 reference

Human evolution. Diabetes running wild

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

The pathogenesis and prevention of diabetes in adults. Genes, autoimmunity, and demography

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

Clinical characteristics, and time course of pancreatic beta-cell function and glutamic acid decarboxylase antibodies in Thai patients with adult-onset Type 1 diabetes: distinction between patients of rapid- and slow-onset.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

Prevalence of diabetes and impaired glucose tolerance in Aragón, Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

Prevalence of diabetes in Catalonia (Spain): an oral glucose tolerance test-based population study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

Prevalence of diabetes mellitus in the population aged 40-69 years in Galicia, northwest Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

Assessing the Impact of Blood Sample Type on the Estimated Prevalence of Impaired Glucose Tolerance and Diabetes Mellitus in Epidemiological Surveys

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

Towards a World Health Organization (WHO) approved standard sample for islet cell antibodies, GAD65 and IA-2 autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

The ethnic distribution of antibodies to glutamic acid decarboxylase: presence and levels of insulin-dependent diabetes mellitus in Europid and Asian subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

Low Prevalence of Antibodies to GAD65 in a 50- to 74-Year-Old General Dutch Population: The Hoorn Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

Protein tyrosine phosphatase-like proteins: link with IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

Antibodies to GAD in Japanese diabetic patients: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

Lack of antibodies to glutamic acid decarboxylase in young adults of the high diabetes prevalence Wanigela people of Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

From diagnosis and classification to complications and therapy. DCCT. Part II? Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

Low prevalence of islet autoimmunity in adult diabetes and low predictive value of islet autoantibodies in the general adult population of northern Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

Glutamate decarboxylase (GAD65) and tyrosine phosphatase-like protein (IA-2) autoantibodies index in a regional population is related to glucose intolerance and body mass index.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

Diagnosing diabetes mellitus--do we need new criteria?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

Epidemiology of diabetes mellitus in the elderly in northern Greece: a population study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

Undiagnosed NIDDM: clinical and public health issues.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

Clinical parameters (body mass index and age) are the best predictors for the need of insulin therapy during the first 18 months of diabetes mellitus in young adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900002-5

7 January 2021

10.1016/S0168-8227(02)00002-5

Identifiers

DOI

1 reference

28 November 2017

1 reference